Your browser doesn't support javascript.
loading
Exploring colistin pharmacodynamics against Klebsiella pneumoniae: a need to revise current susceptibility breakpoints.
Tsala, Marilena; Vourli, Sophia; Georgiou, Panagiota-Christina; Pournaras, Spyros; Tsakris, Athanasios; Daikos, George L; Mouton, Johan W; Meletiadis, Joseph.
Afiliação
  • Tsala M; Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Vourli S; Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Georgiou PC; Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Pournaras S; Clinical Microbiology Laboratory, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Tsakris A; Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Daikos GL; Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Mouton JW; First Department of Propaedeutic Medicine, Laikon Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • Meletiadis J; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands.
J Antimicrob Chemother ; 73(4): 953-961, 2018 04 01.
Article em En | MEDLINE | ID: mdl-29377998

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article